Clinical Trial Update: Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety of vorinostat and its effect on HIV transcription in patients on suppressive combination antiretroviral ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vorinostat (Zolinza) (vorinostat)

Snippet

Sponsor: Bayside Health | Conditions: HIV Positive | Phase 2 | Status: UNKNOWN